Silicon Valley Capital Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $109K | Buy |
589
+16
| +3% | +$2.97K | 0.01% | 101 |
|
2025
Q1 | $118K | Buy |
573
+56
| +11% | +$11.5K | 0.02% | 96 |
|
2024
Q4 | $91.8K | Sell |
517
-198
| -28% | -$35.2K | 0.01% | 107 |
|
2024
Q3 | $141K | Sell |
715
-6
| -0.8% | -$1.18K | 0.02% | 85 |
|
2024
Q2 | $124K | Sell |
721
-41
| -5% | -$7.03K | 0.02% | 87 |
|
2024
Q1 | $139K | Sell |
762
-158
| -17% | -$28.8K | 0.02% | 77 |
|
2023
Q4 | $143K | Sell |
920
-132
| -13% | -$20.5K | 0.02% | 74 |
|
2023
Q3 | $157K | Sell |
1,052
-105
| -9% | -$15.6K | 0.03% | 70 |
|
2023
Q2 | $156K | Sell |
1,157
-100
| -8% | -$13.5K | 0.03% | 75 |
|
2023
Q1 | $200K | Sell |
1,257
-62
| -5% | -$9.88K | 0.04% | 68 |
|
2022
Q4 | $213K | Buy |
+1,319
| New | +$213K | 0.05% | 66 |
|
2022
Q3 | – | Sell |
-1,475
| Closed | -$226K | – | 66 |
|
2022
Q2 | $226K | Sell |
1,475
-49
| -3% | -$7.51K | 0.05% | 58 |
|
2022
Q1 | $247K | Buy |
1,524
+8
| +0.5% | +$1.3K | 0.04% | 64 |
|
2021
Q4 | $205K | Buy |
+1,516
| New | +$205K | 0.03% | 75 |
|
2021
Q2 | – | Sell |
-1,978
| Closed | -$214K | – | 62 |
|
2021
Q1 | $214K | Sell |
1,978
-114
| -5% | -$12.3K | 0.05% | 64 |
|
2020
Q4 | $224K | Buy |
+2,092
| New | +$224K | 0.05% | 56 |
|